Optimal post-remission therapy for flow-cytometry minimal residual disease positive patients with acute myeloid leukemia

被引：0
|
作者：
Venditti, A. [1 ]
Buccisano, F. [1 ]
Maurillo, L. [1 ]
Del Principe, M. I. [1 ]
Del Poeta, G. [1 ]
Ottaviani, L. [1 ]
Sarlo, C. [1 ]
Ammatuna, E. [1 ]
Fraboni, D. [1 ]
Imo-Consalvo, M. [1 ]
Amadori, S. [1 ]
机构：
[1] Univ Roma Tor Vergata, Rome, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0486
引用
收藏
页码：180 / 180
页数：1
相关论文
共 50 条
  • [41] Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia
    Kern, W
    Voskova, D
    Schoch, C
    Hiddemann, W
    Schnittger, S
    Haferlach, T
    BLOOD, 2004, 104 (10) : 3078 - 3085
  • [42] DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE LYMPHOBLASTIC-LEUKEMIA BY FLOW-CYTOMETRY WITH MONOCLONAL-ANTIBODIES
    IMAMURA, N
    KURAMOTO, A
    AMERICAN JOURNAL OF HEMATOLOGY, 1991, 38 (04) : 332 - 334
  • [43] Statistical validation of a threshold to discriminate flow-cytometry minimal residual disease (MRD) levels with prognostic significance in acute myeloid leukemia (AML).
    Buccisano, Francesco
    Maurillo, Luca
    Gattei, Valter
    Del Poeta, Giovanni
    Del Principe, Maria Ilaria
    Panetta, Paola
    Fraboni, Daniela
    Consalvo, Maria Irno
    Ottaviani, Licia
    Renzi, Daniela
    Faccia, Sabrina
    Sarlo, Chiara
    Lo Coco, Francesco
    Amadori, Sergio
    Venditti, Adriano
    BLOOD, 2006, 108 (11) : 651A - 652A
  • [44] MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA PATIENTS
    Van der Velden, Vincent
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2009, 76B (06) : 416 - 416
  • [45] Minimal residual disease in patients with acute myeloid leukemia
    Galtseva, IV
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 1998, 43 (01): : 10 - 11
  • [46] Post-remission therapy in acute myeloid leukemia: what should I do now?
    Blum, William
    HAEMATOLOGICA, 2008, 93 (06) : 801 - 805
  • [47] Determination of minimal residual disease in patients with acute myeloid leukemia by multiparameter flow cytometry: Prognostic impact at different checkpoints
    Kern, W
    Voskova, D
    Schoch, C
    Hiddemann, W
    Schnittger, S
    Haferlach, T
    BLOOD, 2004, 104 (11) : 117A - 117A
  • [48] Persistence of minimal residual disease assessed by multiparameter flow cytometry is highly prognostic in younger patients with acute myeloid leukemia
    Ravandi, Farhad
    Jorgensen, Jeffrey
    Borthakur, Gautam
    Jabbour, Elias
    Kadia, Tapan
    Pierce, Sherry
    Brandt, Mark
    Wang, Sa
    Konoplev, Sergej
    Wang, Xuemei
    Huang, Xuelin
    Daver, Naval
    DiNardo, Courtney
    Andreeff, Michael
    Konopleva, Marina
    Estrov, Zeev
    Garcia-Manero, Guillermo
    Cortes, Jorge
    Kantarjian, Hagop
    CANCER, 2017, 123 (03) : 426 - 435
  • [49] Use of Minimal Residual Disease in Acute Myeloid Leukemia Therapy
    Sebastian Schwind
    Madlen Jentzsch
    Enrica Bach
    Sebastian Stasik
    Christian Thiede
    Uwe Platzbecker
    Current Treatment Options in Oncology, 2020, 21
  • [50] Use of Minimal Residual Disease in Acute Myeloid Leukemia Therapy
    Schwind, Sebastian
    Jentzsch, Madlen
    Bach, Enrica
    Stasik, Sebastian
    Thiede, Christian
    Platzbecker, Uwe
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (01)
12345